Avalo Therapeutics Inc. (AVTX)
Market Closed
17 Jul, 20:00
$
19. 37
+1.49
+8.3333%
$
216.96M Market Cap
- P/E Ratio
- Div Yield
1.24M Volume
- Eps
$ 17.88
Previous Close 
Want to track AVTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Avalo Therapeutics Inc. (AVTX) Statistics
Valuation metrics
Market Cap 216.96M
Enterprise value 196.11M
Trailing P/E (ttm) -3.32
Forward P/E -
PEG ratio 0.03
Price/Sales (ttm) 3,707.92
Price/Book (mrq) 5.7
Enterprise Value/Revenue 3,323.85
Enterprise Value/EBITDA -2.33
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.24M
Average volume (90 days) 2.38M
Price summary
52-Week low 4.81
52-Week high 24.27
Beta -
50-Day moving average 17.34
200-Day moving average 15.95
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:240
Last split Date 29 Dec 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1,436.27%
Operating margin -1,341.64%
Operational effectiveness
Return on assets -0.85%
Return on equity -0.98%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -4.21
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.08
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 7.66%
Book value per share (mrq) 3.4
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
